A detailed history of Sebold Capital Management, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Sebold Capital Management, Inc. holds 25,818 shares of VTRS stock, worth $267,990. This represents 0.21% of its overall portfolio holdings.

Number of Shares
25,818
Previous 21,075 22.51%
Holding current value
$267,990
Previous $228 Million 35.06%
% of portfolio
0.21%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

BUY
$11.27 - $13.53 $53,453 - $64,172
4,743 Added 22.51%
25,818 $308 Million
Q3 2023

Oct 23, 2023

BUY
$9.59 - $11.35 $7,403 - $8,762
772 Added 3.8%
21,075 $208 Million
Q2 2023

Jul 28, 2023

SELL
$9.02 - $10.29 $7,910 - $9,024
-877 Reduced 4.14%
20,303 $203 Million
Q4 2022

May 11, 2023

BUY
$8.72 - $11.56 $184,689 - $244,840
21,180 New
21,180 $236 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Sebold Capital Management, Inc. Portfolio

Follow Sebold Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sebold Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sebold Capital Management, Inc. with notifications on news.